Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIGER
2016-004507-31Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Feb 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of methylprednisolone and prednisone in IgA nephropathy (IgAN), sponsored by Assistance publique - Hôpitaux de Paris. Started Feb 2017; status: completed.
02
Drugs
methylprednisoloneprednisone
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on 2016-004507-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004507-31.